Teschner, A. (2022). Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy. https://doi.org/10.11588/heidok.00033201
Chicago Style (17th ed.) CitationTeschner, Annkathrin. Use of TCR Antibody Fusion Proteins as Bispecific Agents for NK and T Cell-mediated Immunotherapy. Heidelberg, 2022. https://doi.org/10.11588/heidok.00033201.
MLA (9th ed.) CitationTeschner, Annkathrin. Use of TCR Antibody Fusion Proteins as Bispecific Agents for NK and T Cell-mediated Immunotherapy. 2022. https://doi.org/10.11588/heidok.00033201.
Warning: These citations may not always be 100% accurate.